Foundation Medicine Stock Symbol. $14 to $16 ipo price: (fmi) stock price today, quote & news | seeking alpha.
After announcing that roche holdings will acquire it for $137 per share in cash, shares in foundation medicine are soaring 28.3% at 11:30 a.m. All of the common stock is being offered by foundation.
Btcy , carrying a zacks. Find the latest 23400 (fmi) stock quote, history, news and other vital information to help you with your stock trading and investing.
on Medicine Stock Symbol
Foundation medicine is registered under the ticker nasdaq:fmi.Foundation medicine plans to create clinical diagnostic tests that can use the latest in genetic sequencing technology to identify personalized cancer therapies for patients.Foundation medicine prices initial public offering of common stock.Foundation medicine trades on the nasdaq under the ticker symbol fmi. what is foundation medicine’s stock price today?
Foundation medicine’s official website is www.foundationmedicine.comFoundation medicine’s stock symbol is fmi what is foundation medicine’s official website?Get foundation medicine, inc.’s stock price today.Interactive chart for 23400 (fmi), analyze all the data with a huge range of indicators.
Ipo date sep 25, 2013Its products provide genetic information about a patient’s cancer that is used by physicians to inform clinical decisions and by biopharmaceutical companies to.Legal name foundation medicine, inc.Mnmd | complete mind medicine (mindmed) inc.
Money raised at ipo $106m;Nasdaq updated jul 31, 2018 12:25 pm fmi 137.00 0.00 (0.00%).One share of fmi stock can currently be purchased for approximately $137.00.Provides molecular information products primarily in the united states.
Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Stock analysis for foundation medicine inc (fmi) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Stock ticker symbol market type;The biotech ipo stampede this year hasn’t led to the same type of success for diagnostics companies—that is, until foundation medicine priced its offering late tuesday.
The company offers foundationone(tm) a molecular information product for the analysis of routine cancer specimens in a clinical setting.Their stock opened with $18.00 in its sep 25, 2013 ipo.Today announced the pricing of its initial public offering of 5,888,888 shares of common stock at a price of $18.00 per share, before underwriting discounts.When foundation medicine went public in.